根据当前血管内治疗纳入标准的股总动脉内切除术和膜片血管成形术的结果。

IF 0.8 Q4 PERIPHERAL VASCULAR DISEASE
Suehyun Park, Taewan Ku, Deokbi Hwang, Woo-Sung Yun, Hyung-Kee Kim, Seung Huh
{"title":"根据当前血管内治疗纳入标准的股总动脉内切除术和膜片血管成形术的结果。","authors":"Suehyun Park,&nbsp;Taewan Ku,&nbsp;Deokbi Hwang,&nbsp;Woo-Sung Yun,&nbsp;Hyung-Kee Kim,&nbsp;Seung Huh","doi":"10.5758/vsi.220040","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to evaluate the outcomes of isolated common femoral endarterectomy with patch angioplasty (IFEA) in the endovascular era.</p><p><strong>Materials and methods: </strong>In 2012-2022, 189 limbs underwent femoral endarterectomy with patch angioplasty. Of them, 45 IFEAs were included. We evaluated safety based on early complications; efficacy with primary patency (PP) and reintervention, above-ankle amputation, or stenosis (RAS)-free survival. We also evaluated lesion characteristics and outcomes according to the inclusion criteria (IC) of vascular mimetic implant-common femoral artery (VMI-CFA) stenting trial.</p><p><strong>Results: </strong>Forty-one patients were male, and 30 IFEAs were required for claudication. No cases of early mortality occurred. Ten limbs (22%) developed local/nonvascular complications (hematoma, 3; lymphocele, 5; wound infection, 2), of which 8 resolved spontaneously. The overall PP and secondary patency rates were 100% at 1 year and 87% and 97% at 3 years, respectively. Twenty-one lesions (47%) did not meet the IC. The PP within the IC was 100% at 1 and 3 years, and the PP outside the IC was 100% at 1 year and 73% at 3 years (P=0.068). The overall RAS-free survival rates were 91% at 1 year and 81% at 3 years. All cases of RAS occurred in lesions outside the IC. The multivariate analysis showed that dialysis was associated with poor RAS-free survival (adjusted odds ratio, 8.56; 95% confidence interval, 1.9-35.5; P=0.005).</p><p><strong>Conclusion: </strong>The recent VMI-CFA trial results should be interpreted with caution. IFEA is a low-risk and durable procedure; however, careful follow-up is warranted in patients undergoing dialysis.</p>","PeriodicalId":52311,"journal":{"name":"Vascular Specialist International","volume":"38 ","pages":"32"},"PeriodicalIF":0.8000,"publicationDate":"2022-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/dd/01/vsi-38-32.PMC9794491.pdf","citationCount":"0","resultStr":"{\"title\":\"Outcomes of Isolated Endarterectomy and Patch Angioplasty of the Common Femoral Artery According to Current Inclusion Criteria for Endovascular Treatment.\",\"authors\":\"Suehyun Park,&nbsp;Taewan Ku,&nbsp;Deokbi Hwang,&nbsp;Woo-Sung Yun,&nbsp;Hyung-Kee Kim,&nbsp;Seung Huh\",\"doi\":\"10.5758/vsi.220040\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study aimed to evaluate the outcomes of isolated common femoral endarterectomy with patch angioplasty (IFEA) in the endovascular era.</p><p><strong>Materials and methods: </strong>In 2012-2022, 189 limbs underwent femoral endarterectomy with patch angioplasty. Of them, 45 IFEAs were included. We evaluated safety based on early complications; efficacy with primary patency (PP) and reintervention, above-ankle amputation, or stenosis (RAS)-free survival. We also evaluated lesion characteristics and outcomes according to the inclusion criteria (IC) of vascular mimetic implant-common femoral artery (VMI-CFA) stenting trial.</p><p><strong>Results: </strong>Forty-one patients were male, and 30 IFEAs were required for claudication. No cases of early mortality occurred. Ten limbs (22%) developed local/nonvascular complications (hematoma, 3; lymphocele, 5; wound infection, 2), of which 8 resolved spontaneously. The overall PP and secondary patency rates were 100% at 1 year and 87% and 97% at 3 years, respectively. Twenty-one lesions (47%) did not meet the IC. The PP within the IC was 100% at 1 and 3 years, and the PP outside the IC was 100% at 1 year and 73% at 3 years (P=0.068). The overall RAS-free survival rates were 91% at 1 year and 81% at 3 years. All cases of RAS occurred in lesions outside the IC. The multivariate analysis showed that dialysis was associated with poor RAS-free survival (adjusted odds ratio, 8.56; 95% confidence interval, 1.9-35.5; P=0.005).</p><p><strong>Conclusion: </strong>The recent VMI-CFA trial results should be interpreted with caution. IFEA is a low-risk and durable procedure; however, careful follow-up is warranted in patients undergoing dialysis.</p>\",\"PeriodicalId\":52311,\"journal\":{\"name\":\"Vascular Specialist International\",\"volume\":\"38 \",\"pages\":\"32\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2022-12-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/dd/01/vsi-38-32.PMC9794491.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vascular Specialist International\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5758/vsi.220040\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular Specialist International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5758/vsi.220040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究旨在评价在血管内时代孤立性股动脉内膜切除术联合膜片血管成形术(IFEA)的效果。材料与方法:2012-2022年,189例肢体行股动脉内膜切除术联合膜片血管成形术。其中包括45个ifea。我们根据早期并发症评估安全性;原发性通畅(PP)和再干预、踝上截肢或无狭窄(RAS)生存的疗效。我们还根据血管模拟植入物-股总动脉(VMI-CFA)支架植入试验的纳入标准(IC)评估病变特征和结果。结果:41例患者为男性,30例患者因跛行需要人工授精。未发生早期死亡病例。10条肢体(22%)出现局部/非血管并发症(血肿,3例;淋巴管瘤5;伤口感染2例,其中8例自愈。1年时总PP和二次通畅率为100%,3年时分别为87%和97%。21个病变(47%)不符合IC。IC内的PP在1年和3年为100%,IC外的PP在1年和3年为100%和73% (P=0.068)。1年和3年的总体无ras生存率分别为91%和81%。所有RAS病例均发生在IC外病变。多因素分析显示,透析与较差的无RAS生存相关(校正优势比为8.56;95%置信区间为1.9-35.5;P = 0.005)。结论:最近的VMI-CFA试验结果应谨慎解读。体外受精是一个低风险和持久的程序;然而,对接受透析的患者进行仔细的随访是必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Outcomes of Isolated Endarterectomy and Patch Angioplasty of the Common Femoral Artery According to Current Inclusion Criteria for Endovascular Treatment.

Outcomes of Isolated Endarterectomy and Patch Angioplasty of the Common Femoral Artery According to Current Inclusion Criteria for Endovascular Treatment.

Outcomes of Isolated Endarterectomy and Patch Angioplasty of the Common Femoral Artery According to Current Inclusion Criteria for Endovascular Treatment.

Purpose: This study aimed to evaluate the outcomes of isolated common femoral endarterectomy with patch angioplasty (IFEA) in the endovascular era.

Materials and methods: In 2012-2022, 189 limbs underwent femoral endarterectomy with patch angioplasty. Of them, 45 IFEAs were included. We evaluated safety based on early complications; efficacy with primary patency (PP) and reintervention, above-ankle amputation, or stenosis (RAS)-free survival. We also evaluated lesion characteristics and outcomes according to the inclusion criteria (IC) of vascular mimetic implant-common femoral artery (VMI-CFA) stenting trial.

Results: Forty-one patients were male, and 30 IFEAs were required for claudication. No cases of early mortality occurred. Ten limbs (22%) developed local/nonvascular complications (hematoma, 3; lymphocele, 5; wound infection, 2), of which 8 resolved spontaneously. The overall PP and secondary patency rates were 100% at 1 year and 87% and 97% at 3 years, respectively. Twenty-one lesions (47%) did not meet the IC. The PP within the IC was 100% at 1 and 3 years, and the PP outside the IC was 100% at 1 year and 73% at 3 years (P=0.068). The overall RAS-free survival rates were 91% at 1 year and 81% at 3 years. All cases of RAS occurred in lesions outside the IC. The multivariate analysis showed that dialysis was associated with poor RAS-free survival (adjusted odds ratio, 8.56; 95% confidence interval, 1.9-35.5; P=0.005).

Conclusion: The recent VMI-CFA trial results should be interpreted with caution. IFEA is a low-risk and durable procedure; however, careful follow-up is warranted in patients undergoing dialysis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.10
自引率
11.10%
发文量
29
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信